A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 10 strange trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $224,556 and 5, calls, for a total amount of $151,010.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $37.5 to $50.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 7339.0 with a total volume of 7,121.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Pfizer's big money trades within a strike price range of $37.5 to $50.0 over the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PFE | PUT | SWEEP | BEARISH | 06/21/24 | $37.50 | $81.8K | 5.6K | 296 |
| PFE | PUT | TRADE | BULLISH | 01/19/24 | $50.00 | $57.3K | 10.0K | 50 |
| PFE | CALL | TRADE | BEARISH | 12/15/23 | $37.50 | $34.3K | 3.4K | 885 |
| PFE | CALL | SWEEP | BULLISH | 09/15/23 | $45.00 | $31.0K | 16.5K | 1.4K |
| PFE | PUT | TRADE | BULLISH | 12/15/23 | $37.50 | $30.1K | 952 | 535 |
Where Is Pfizer Standing Right Now?
- With a volume of 6,228,981, the price of PFE is down -0.96% at $38.69.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 85 days.
What The Experts Say On Pfizer:
- B of A Securities has decided to maintain their Neutral rating on Pfizer, which currently sits at a price target of $45.
- Morgan Stanley has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $44.
- Barclays has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $40.
- Credit Suisse has decided to maintain their Outperform rating on Pfizer, which currently sits at a price target of $47.
- Barclays has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $43.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
